{"id":8027,"date":"2026-05-11T15:03:28","date_gmt":"2026-05-11T15:03:28","guid":{"rendered":"https:\/\/lorexworks.com\/blog\/?p=8027"},"modified":"2026-05-14T15:07:45","modified_gmt":"2026-05-14T15:07:45","slug":"doctor-on-social-media-educational-content-vs-covert-advertising","status":"publish","type":"post","link":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/","title":{"rendered":"Doctor on Social Media: Educational Content vs Covert Advertising\u00a0"},"content":{"rendered":"\n<h1>Doctor on Social Media: Educational Content vs. Covert Advertising \u2013 Legal Boundaries and Risks<\/h1>\n\n<div style=\"background:#f4f4f4; padding:10px; margin-bottom:20px; border-left:4px solid #ff0000;\">\n  <p style=\"margin:0; font-size:14px;\"><strong>Disclaimer:<\/strong> This content is for educational and informational purposes only and does not constitute legal advice. Healthcare regulations vary significantly by jurisdiction. Physicians should consult their local medical association or legal counsel before implementing any digital content strategy.<\/p>\n<\/div>\n\n<p>Social media has become an essential channel for physicians to share knowledge, correct misinformation, and engage with patients. Yet the line between <strong>educational content<\/strong> and <strong>covert advertising<\/strong> is dangerously thin. Across jurisdictions, regulators have responded with a wave of new rules: Turkey&#8217;s 2025 Regulation on Promotion and Information Activities in Healthcare Services introduced strict prohibitions on before\u2011after photos, treatment guarantees, and demand\u2011generating content; the American Medical Association (AMA) published a landmark deepfake and AI\u2011impersonation framework in April 2026; the UK General Medical Council (GMC) updated its standalone social\u2011media guidance in 2024; France&#8217;s National Council of Physicians (CNOM) issued a first\u2011of\u2011its\u2011kind charter for physician content creators in January 2025; Poland amended its Code of Medical Ethics to permit\u2014but tightly regulate\u2014physician advertising on social media; and Germany&#8217;s Higher Regional Court of Cologne (OLG K\u00f6ln) established joint liability for pharmaceutical companies and physician\u2011influencers in September 2025. Enforcement is real: state medical boards in the United States, the GMC&#8217;s Medical Practitioners Tribunal Service (MPTS) in the United Kingdom, and Turkey&#8217;s Provincial Evaluation Commissions have all imposed sanctions\u2014ranging from fines to license revocation\u2014for social\u2011media misconduct. This article provides a deep, multi\u2011jurisdictional analysis of the legal and ethical boundaries governing physician\u2011generated content, drawing on primary regulatory sources and official guidance from medical oversight bodies across North America, Europe, and Asia\u2011Pacific.<\/p>\n\n<p><em>This article is part of a strategic content series powered by <strong>LOREX<\/strong> \u2013 an IP development model for experts.<\/em><\/p>\n\n<h2>1. The Foundational Prohibition: Why Physicians Cannot Advertise Like Businesses<\/h2>\n\n<p>Unlike commercial enterprises, the medical profession is built on <strong>public service, trust, and patient welfare<\/strong>. Every major medical\u2011ethics code derives from the principle that the patient&#8217;s interest takes precedence over the physician&#8217;s commercial interest. This principle is the source of the advertising restrictions that apply worldwide.<\/p>\n\n<h3>1.1 Turkey: The 2025 Regulation in Context<\/h3>\n\n<p>Turkey&#8217;s regulatory framework is among the most restrictive globally. The primary legal instruments include:<\/p>\n<ul>\n  <li><strong>Law No. 1219 on the Practice of Medicine and Medical Sciences<\/strong> \u2013 Articles 24 and 40 restrict physician announcements to name, specialty, practice address, and working hours only. Any content exceeding these narrow categories risks classification as prohibited advertising.<\/li>\n  <li><strong>Medical Deontology Regulation (T\u0131bbi Deontoloji Nizamnamesi)<\/strong> \u2013 Article 8 prohibits giving the medical profession a commercial character and bans thank\u2011you announcements and patient testimonials. Article 26 provides for criminal liability in cases of confidentiality breaches.<\/li>\n  <li><strong>2025 Regulation on Promotion and Information Activities in Healthcare Services<\/strong> \u2013 The most comprehensive digital\u2011era framework, effective November 2025. <a href=\"https:\/\/www.tdb.org.tr\/icerik_goster.php?Id=4361\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Turkish Dental Association)<\/a><\/li>\n<\/ul>\n\n<p>The core principle is that medical services cannot be marketed as commodities. Any content that <strong>creates demand<\/strong> for a specific physician or clinic\u2014even indirectly\u2014may be classified as prohibited advertising under Article 5 of the 2025 Regulation.<\/p>\n\n<h3>1.2 United States: AMA Code of Medical Ethics Opinion 2.3.2<\/h3>\n\n<p>Opinion 2.3.2, <em>Physicians&#8217; Use of Social Media for Product Promotion and Compensation<\/em>, states unequivocally that physicians and medical students &#8220;cannot realistically separate their personal and professional personas entirely online and should curate their social media presence accordingly.&#8221; Key obligations include:<\/p>\n<ul>\n  <li>Maintain appropriate boundaries of the patient\u2013physician relationship in accordance with ethics guidance if interacting with patients through social media.<\/li>\n  <li>Use privacy settings to safeguard personal information and content, but be aware that once on the internet, content is likely there permanently. Routinely monitor one&#8217;s social media presence to ensure that personal and professional information published by others is accurate and appropriate.<\/li>\n  <li><strong>Publicly disclose any financial interests<\/strong> related to social media content, including paid partnerships and corporate sponsorships.<\/li>\n  <li>When using social media to disseminate medical or health\u2011care information, ensure that such information is <strong>useful and accurate based on professional medical judgment<\/strong>.<\/li>\n<\/ul>\n\n<p>Source: AMA Code of Medical Ethics, Opinion 2.3.2, available at <a href=\"https:\/\/code-medical-ethics.ama-assn.org\/ethics-opinions\/physicians-use-social-media-product-promotion-and-compensation\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/code-medical-ethics.ama-assn.org\/ethics-opinions\/physicians-use-social-media-product-promotion-and-compensation<\/a>.<\/p>\n\n<p>The AMA&#8217;s position is grounded in fiduciary duty: physicians&#8217; recommendations carry the weight of professional authority, and any undisclosed financial interest in a product or service they promote constitutes a breach of that duty. The Federal Trade Commission (FTC) reinforces this through its <strong>Endorsement Guides<\/strong> (updated 2023), which require clear and conspicuous disclosure of material connections\u2014using labels like #ad or #sponsored\u2014in all influencer and expert endorsements. Source: <a href=\"https:\/\/www.ftc.gov\/business-guidance\/resources\/ftcs-endorsement-guides-what-people-are-asking\" target=\"_blank\" rel=\"noopener noreferrer\">FTC Endorsement Guides<\/a>.<\/p>\n\n<h3>1.3 United Kingdom: GMC&#8217;s <em>Using Social Media as a Medical Professional<\/em> (2024)<\/h3>\n\n<p>The GMC&#8217;s standalone guidance, which came into effect on 30 January 2024 and was updated on 13 December 2024 to include physician associates and anaesthesia associates, makes clear that social\u2011media communications are subject to the same professional standards as any other public communication.<\/p>\n\n<p>Key provisions include:<\/p>\n<ul>\n  <li>&#8220;You must take reasonable steps to make sure that the information you communicate on social media as a medical professional is not false or misleading and does not exploit people&#8217;s vulnerability or lack of medical knowledge. You must not misrepresent your experience and qualifications.&#8221;<\/li>\n  <li>&#8220;If you use social media to advertise your services, or use your professional position to promote or endorse any other services or products, you must be open and honest about any interests you have that may influence (or could be seen to influence) the recommendations you make.&#8221;<\/li>\n  <li>When commenting on health or healthcare issues, medical professionals &#8220;should usually say who you are&#8221;\u2014anonymity does not shield physicians from accountability.<\/li>\n  <li>Physicians are advised not to &#8220;friend&#8221; or establish personal social\u2011media connections with current patients, as doing so blurs professional boundaries.<\/li>\n<\/ul>\n\n<p>Source: GMC, <em>Using Social Media as a Medical Professional<\/em>, available at <a href=\"https:\/\/www.gmc-uk.org\/professional-standards\/the-professional-standards\/using-social-media-as-a-medical-professional\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.gmc-uk.org\/professional-standards\/the-professional-standards\/using-social-media-as-a-medical-professional<\/a>.<\/p>\n\n<p><a href=\"\/lorex-en.html#problem\" target=\"_blank\">Explore the core problem LOREX solves \u2192<\/a><\/p>\n\n<h2>2. What Is Permitted? Educational Content Across Jurisdictions<\/h2>\n\n<p>Drawing together the Turkish, AMA, GMC, and European frameworks, a clear taxonomy emerges distinguishing permissible educational content from prohibited promotion.<\/p>\n\n<h3>2.1 Turkey: The 2025 Regulation&#8217;s Information\u2013Promotion Distinction<\/h3>\n\n<p>The 2025 Regulation distinguishes between <strong>information<\/strong> (permitted) and <strong>promotion<\/strong> (prohibited). Educational content is allowed if it meets strict criteria:<\/p>\n<ul>\n  <li>It is based on <strong>scientific evidence<\/strong> and peer\u2011reviewed knowledge.<\/li>\n  <li>It does not <strong>create demand<\/strong> for a specific healthcare provider.<\/li>\n  <li>It includes a mandatory disclaimer: <em>&#8220;This content is for informational purposes only. Please consult your physician for diagnosis and treatment.&#8221;<\/em><\/li>\n  <li>It does not contain <strong>pricing information, discounts, or campaigns<\/strong>.<\/li>\n  <li>It does not use <strong>superlatives<\/strong> such as &#8220;best,&#8221; &#8220;most successful,&#8221; or &#8220;100% guaranteed.&#8221;<\/li>\n<\/ul>\n\n<p>For example, a cardiologist may post a video explaining hypertension risk factors. That is education. The same cardiologist posting &#8220;I treat hypertension better than anyone in Istanbul&#8221; is advertising\u2014and subject to discipline.<\/p>\n\n<h3>2.2 United Kingdom: Public\u2011Interest Justification<\/h3>\n\n<p>The GMC acknowledges that social media can be used &#8220;to benefit patient care, education and learning.&#8221; This public\u2011interest rationale permits physicians to share evidence\u2011based health information, correct misinformation, and participate in public discourse\u2014provided the content meets the honesty and transparency standards set out in the guidance. The key safeguard is that the physician must identify himself or herself by name and qualification, enabling the audience to assess the credibility of the information.<\/p>\n\n<h3>2.3 France: The CNOM Charter for Physician Content Creators (2025)<\/h3>\n\n<p>In January 2025, the Conseil National de l&#8217;Ordre des M\u00e9decins (CNOM) published a 10\u2011principle <em>Charte du m\u00e9decin cr\u00e9ateur de contenu responsable<\/em> (Charter for the Responsible Physician Content Creator). The charter was developed in consultation with physician content creators and platform experts and represents one of the most forward\u2011looking regulatory instruments in Europe. It requires that physician\u2011created content:<\/p>\n<ul>\n  <li>Be scientifically rigorous and accessible.<\/li>\n  <li>Be clearly identified as coming from a qualified medical professional.<\/li>\n  <li>Not present unverified hypotheses as established fact.<\/li>\n  <li>Respect all ethical obligations\u2014including professional confidentiality, dignity, and collegiality\u2014applicable to any other form of medical communication.<\/li>\n  <li>Refrain from promoting unproven or non\u2011conventional practices.<\/li>\n<\/ul>\n\n<p>Source: CNOM, <em>Une charte du m\u00e9decin cr\u00e9ateur de contenu responsable<\/em>, 10 January 2025, available at <a href=\"https:\/\/www.conseil-national.medecin.fr\/publications\/actualites\/charte-medecin-createur-contenu-responsable\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.conseil-national.medecin.fr\/publications\/actualites\/charte-medecin-createur-contenu-responsable<\/a>.<\/p>\n\n<p>The CNOM Charter does not relax the advertising prohibition; it makes it operational in the digital environment, acknowledging that physician\u2011generated social\u2011media content can be a public good\u2014provided it meets the same ethical standards as traditional medical publishing.<\/p>\n\n<h3>2.4 Poland: The 2025 Amendment to the Code of Medical Ethics (KEL)<\/h3>\n\n<p>Poland has taken one of the most significant liberalizing steps in Europe. Effective 1 January 2025, an amended <em>Kodeks Etyki Lekarskiej<\/em> (KEL)\u2014adopted by the Extraordinary XVI National Congress of Physicians in May 2024\u2014introduces, for the first time, direct provisions on physicians&#8217; use of social media. The Naczelna Izba Lekarska (NIL), Poland&#8217;s supreme medical chamber, stated that the most important changes &#8220;concern social media in the medical profession\u2014they constitute the essence of ethics and responsibility of physicians in using online platforms.&#8221;<\/p>\n\n<p>The amended KEL explicitly permits physicians and dentists to advertise their services on social media. However, the permission is not unlimited:<\/p>\n<ul>\n  <li>Advertising must be <strong>transparent and honest<\/strong>.<\/li>\n  <li>A physician must not use his or her professional authority to promote products or services that are <strong>unrelated to the practice of medicine<\/strong>.<\/li>\n  <li>The physician&#8217;s public communication must not violate the core ethical values of the profession, including patient dignity and professional integrity.<\/li>\n<\/ul>\n\n<p>Source: NIL, <em>Nowy KEL od 1 stycznia 2025<\/em>, available at <a href=\"https:\/\/nil.org.pl\/drukuj\/8721\/1\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/nil.org.pl\/drukuj\/8721\/1<\/a>.<\/p>\n\n<p>Poland&#8217;s approach represents a <strong>controlled opening<\/strong>: the physician is allowed to inform the public about his or her services, but the informational function must not be conflated with commercial exploitation of the physician&#8217;s professional standing.<\/p>\n\n<p><a href=\"\/lorex-en.html#lorex\" target=\"_blank\">Learn more about the LOREX model for compliant expert content \u2192<\/a><\/p>\n\n<h2>3. Strictly Prohibited Practices: A Comparative Table<\/h2>\n\n<p>The following practices are explicitly or presumptively banned across the surveyed jurisdictions:<\/p>\n\n<div style=\"overflow-x: auto; margin: 1.5rem 0;\">\n  <table style=\"min-width: 700px; width: 100%; border-collapse: collapse; background: #fff; border: 1px solid #ddd;\">\n    <thead>\n      <tr style=\"background-color: #f5f5f5;\">\n        <th style=\"padding: 12px; border: 1px solid #ddd; text-align: left;\">Prohibited Act<\/th>\n        <th style=\"padding: 12px; border: 1px solid #ddd; text-align: left;\">Example<\/th>\n        <th style=\"padding: 12px; border: 1px solid #ddd; text-align: left;\">Primary Legal\/Regulatory Basis<\/th>\n       <\/tr>\n    <\/thead>\n    <tbody>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Before\u2011after photos<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">&#8220;See my rhinoplasty results&#8221;<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Art. 5(2)(\u00e7), Turkish 2025 Regulation; GMC boundary guidance; CNOM Charter; AMA professionalism standards<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Treatment guarantees<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">&#8220;100% success rate&#8221;<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Art. 5(2)(b), Turkish 2025 Regulation; GMC para. 11 (must not mislead); medical malpractice liability in all jurisdictions<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Discounts or campaigns<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">&#8220;20% off Botox this month&#8221;<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Art. 5(2)(e), Turkish 2025 Regulation; commercial language prohibited; GMC exploitation concern<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Patient testimonials<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">&#8220;Read what my patients say&#8221;<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Art. 5(2)(d), Turkish 2025 Regulation; Medical Board of Australia Advertising Guidelines; India NMC Regulations<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Comparative superiority claims<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">&#8220;Better than any other clinic in London&#8221;<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Art. 5(2)(\u00e7), Turkish 2025 Regulation; GMC honesty duty; AMA professionalism duty<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Unsolicited direct messaging<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">DM to potential patient offering services<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Solicitation; GMC boundary guidance; may constitute unprofessional conduct before U.S. state boards<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>Undisclosed financial promotion<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Endorsing a supplement without disclosing payment<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">FTC Endorsement Guides (2023); AMA Opinion 2.3.2; GMC para. 12; OLG K\u00f6ln, 6 U 118\/24 (joint liability)<\/td>\n      <\/tr>\n      <tr>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\"><strong>AI\u2011generated deepfakes or impersonation<\/strong><\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">Synthetic video of a physician endorsing an unapproved treatment<\/td>\n        <td style=\"padding: 12px; border: 1px solid #ddd;\">AMA 2026 Deepfake Framework; CNOM Charter (no unverified claims); potential HIPAA\/KVKK violations<\/td>\n      <\/tr>\n    <\/tbody>\n  <\/table>\n<\/div>\n\n<p>Violations trigger a multi\u2011stage enforcement process in Turkey: first, a warning and content removal request; second, administrative fines (doubling for repeat offenses); third, referral to the medical chamber for professional discipline, which can include temporary or permanent license suspension. Equivalent escalation mechanisms exist in the UK (GMC investigation \u2192 MPTS tribunal \u2192 erasure from the register), the United States (state medical board investigation \u2192 license suspension or revocation), and Australia (Medical Board referral \u2192 disciplinary tribunal).<\/p>\n\n<h2>4. The Special Case of Before\u2011After Photos and AI\u2011Generated Images<\/h2>\n\n<p>Before\u2011after photos occupy a particularly sensitive position across all surveyed jurisdictions. Both the CNOM Charter and the GMC&#8217;s boundary guidance indicate that even when a patient consents, such images are inherently promotional: they selectively present favorable outcomes and create expectations that cannot be guaranteed for every patient.<\/p>\n\n<h3>4.1 Turkey: Presumptive Advertising<\/h3>\n\n<p>Under the 2025 Regulation, before\u2011after photos are treated as <strong>presumptive advertising<\/strong> and are banned in most contexts, even with patient consent. If a physician wishes to use such images for genuine educational purposes (e.g., academic presentation), strict rules apply:<\/p>\n<ul>\n  <li>Written consent must be obtained using a specific &#8220;Visual Content Consent Form&#8221; (Annex\u20111), different from general treatment consent. <a href=\"https:\/\/www.tdb.org.tr\/icerik_goster.php?Id=4361\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: TDB)<\/a><\/li>\n  <li>No financial incentive or discount may be given in exchange for consent.<\/li>\n  <li>No filters, Photoshop, or misleading lighting are allowed\u2014images must be raw and authentic.<\/li>\n  <li>The date of the procedure and the date of the photo must be clearly stated.<\/li>\n  <li>Comments must be disabled on any social media post containing clinical images.<\/li>\n<\/ul>\n\n<h3>4.2 United States: The AMA&#8217;s 2026 Deepfake Framework<\/h3>\n\n<p>The AMA&#8217;s <strong>2026 policy framework on AI\u2011generated deepfakes<\/strong>, announced in April 2026, represents the most comprehensive regulatory response globally to the intersection of AI and physician identity. Built on seven key principles, the framework establishes:<\/p>\n<ol>\n  <li><strong>Physician Identity Is a Protected Right<\/strong>\u2014a physician&#8217;s name, image, likeness, voice, and digital replicas are protected and may only be used with affirmative, informed consent.<\/li>\n  <li><strong>Prohibition on Deceptive Medical Impersonation<\/strong>\u2014any AI\u2011generated or altered content impersonating a physician, especially if it falsely conveys endorsement, is prohibited and treated as deception.<\/li>\n  <li><strong>Informed, Opt\u2011In, and Revocable Consent<\/strong>\u2014consent must be specific, explicit, and revocable at any time.<\/li>\n  <li><strong>Mandatory Labeling and Transparency<\/strong>\u2014all AI\u2011generated or altered depictions must be clearly labeled in plain language and carry a digital watermark.<\/li>\n  <li><strong>Shared Responsibility<\/strong>\u2014platforms, hospitals, and AI vendors share responsibility for preventing impersonation.<\/li>\n  <li><strong>Enforcement and Practical Remedies<\/strong>\u2014physicians must have access to takedown mechanisms and remedies.<\/li>\n  <li><strong>Minimizing Administrative Burden<\/strong>\u2014identity protection should be the default.<\/li>\n<\/ol>\n\n<p>Source: AMA, <em>AMA urges physician protections against AI deepfake impersonation<\/em>, 29 April 2026, available at <a href=\"https:\/\/www.ama-assn.org\/press-center\/ama-press-releases\/ama-urges-physician-protections-against-ai-deepfake-impersonation\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.ama-assn.org\/press-center\/ama-press-releases\/ama-urges-physician-protections-against-ai-deepfake-impersonation<\/a>.<\/p>\n\n<p>The practical implication is clear: a physician who uses AI to generate or alter an image of a patient\u2014even with the patient&#8217;s consent\u2014may be in breach of multiple ethical obligations, including the duty of honesty, the duty to maintain professional boundaries, and, if the image is used without proper labeling, the emerging duty of transparency regarding synthetic content.<\/p>\n\n<h2>5. European Developments: France, Germany, and Poland in Depth<\/h2>\n\n<h3>5.1 France: The CNOM Charter as a Model for Regulated Participation<\/h3>\n\n<p>The CNOM&#8217;s 2025 Charter is significant because it <strong>acknowledges and legitimizes the physician content creator<\/strong> while imposing professional\u2011grade standards. The Charter was adopted after extensive consultation with practicing physician\u2011influencers, platform representatives, and ethics experts, reflecting a participatory regulatory approach that contrasts with the more prescriptive Turkish model.<\/p>\n\n<p>Key operational requirements include: (i) content must be identifiable as coming from a physician; (ii) the physician must cite his or her specialty and qualifications; (iii) scientific claims must be sourced to peer\u2011reviewed evidence; (iv) speculative or hypothetical statements must be clearly labeled as such; and (v) the physician must not use his or her professional authority to endorse commercial products unrelated to medical practice. Source: <a href=\"https:\/\/www.conseil-national.medecin.fr\/publications\/actualites\/charte-medecin-createur-contenu-responsable\" target=\"_blank\" rel=\"noopener noreferrer\">CNOM Charter<\/a>.<\/p>\n\n<h3>5.2 Germany: Joint Liability for Physician\u2011Influencers and Sponsors<\/h3>\n\n<p>On 11 September 2025, the Higher Regional Court of Cologne (Oberlandesgericht K\u00f6ln, case no. 6 U 118\/24) issued a landmark ruling that significantly expanded liability for health\u2011related advertising on social media. The court held that pharmaceutical companies and paid influencers share <strong>joint responsibility<\/strong> for ensuring compliance with the <em>Heilmittelwerbegesetz<\/em> (HWG, the German Medicines Advertising Act).<\/p>\n\n<p>Under the ruling, mandatory warning statements required by the HWG must appear in all audiovisual formats, including short\u2011form social\u2011media reels. The practical effect is that a physician\u2011influencer who fails to include the required statutory warnings in a sponsored post can be held jointly liable alongside the sponsoring company. This aligns with a broader European trend: the European Commission is currently evaluating a <em>Digital Fairness Act<\/em> that would impose further transparency obligations on digital advertising, including in the healthcare sector. Source: OLG K\u00f6ln, judgment of 11 September 2025, 6 U 118\/24.<\/p>\n\n<h3>5.3 Poland: The Controlled Opening<\/h3>\n\n<p>Poland&#8217;s 2025 amendment to the KEL represents the most liberal approach in Europe, explicitly permitting physician advertising on social media for the first time. The NIL&#8217;s rationale was that physicians needed clear rules for the digital environment rather than a blanket prohibition that was increasingly unenforceable. However, the permission is bounded by the principle that the physician must not commercialize professional authority: endorsing products or services unrelated to medicine remains prohibited, and all advertising must be truthful and transparent. Source: <a href=\"https:\/\/nil.org.pl\/drukuj\/8721\/1\" target=\"_blank\" rel=\"noopener noreferrer\">NIL, Nowy KEL<\/a>.<\/p>\n\n<h2>6. Global Regulatory Comparison: Australia and India<\/h2>\n\n<h3>6.1 Australia: The Testimonial Ban<\/h3>\n\n<p>The Medical Board of Australia&#8217;s <em>Guidelines for Advertising Regulated Health Services<\/em> impose one of the strictest testimonial bans in the world. The guidelines prohibit the use of patient testimonials in advertising a regulated health service. While patients are free to share their views on personal social\u2011media accounts, a practitioner <strong>must not reproduce or use those comments<\/strong> in his or her own advertising or professional content. This prohibition applies even if the patient voluntarily provides the testimonial and consents to its use.<\/p>\n\n<p>Source: Medical Board of Australia, <em>Guidelines for Advertising Regulated Health Services<\/em>, available at <a href=\"https:\/\/www.medicalboard.gov.au\/Codes-Guidelines-Policies\/Guidelines-for-advertising-regulated-health-services.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.medicalboard.gov.au\/Codes-Guidelines-Policies\/Guidelines-for-advertising-regulated-health-services.aspx<\/a>.<\/p>\n\n<h3>6.2 India: The NMC&#8217;s Prohibitive Approach<\/h3>\n\n<p>The National Medical Commission of India has issued regulations under the National Medical Commission Act, 2019, that prohibit registered medical practitioners from soliciting patients through social media, advertising their services, or publishing testimonials. The underlying principle is that any promotional activity that could be construed as canvassing for patients is incompatible with the dignity of the medical profession. Source: <a href=\"https:\/\/www.nmc.org.in\" target=\"_blank\" rel=\"noopener noreferrer\">National Medical Commission<\/a>.<\/p>\n\n<h2>7. Patient Privacy: HIPAA, GDPR, KVKK, and Professional Confidentiality<\/h2>\n\n<p>A recurring theme across all jurisdictions is the primacy of patient privacy. The legal frameworks differ in structure but converge in substance.<\/p>\n\n<h3>7.1 United States: HIPAA<\/h3>\n\n<p>The <strong>HIPAA Privacy Rule<\/strong> (45 CFR Part 160 and Subparts A and E of Part 164) establishes that protected health information (PHI) may not be disclosed on social media without the patient&#8217;s written authorization\u2014except in narrow, specifically defined circumstances. The rule applies to all &#8220;covered entities,&#8221; including individual physicians in private practice. Penalties for non\u2011compliance range from civil monetary penalties to criminal prosecution in cases of knowing or fraudulent disclosure. Source: <a href=\"https:\/\/www.hhs.gov\/hipaa\/for-professionals\/privacy\/laws-regulations\/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">HHS, Summary of the HIPAA Privacy Rule<\/a>.<\/p>\n\n<h3>7.2 Turkey: KVKK and Confidentiality Obligations<\/h3>\n\n<p>Under Turkey&#8217;s KVKK (Law No. 6698 on the Protection of Personal Data), health data is considered <strong>special category personal data<\/strong>. Key requirements include:<\/p>\n<ul>\n  <li>Explicit, written, and informed consent must be obtained before any patient image or case discussion is shared.<\/li>\n  <li>Consent must be revocable at any time without justification.<\/li>\n  <li>Even anonymized data may be re\u2011identifiable\u2014courts have found that pixelated faces or blurred tattoos are insufficient to protect identity.<\/li>\n  <li>Violations can result in administrative fines and criminal prosecution for breach of confidentiality under Article 26 of the Medical Deontology Regulation.<\/li>\n<\/ul>\n\n<h3>7.3 United Kingdom and Europe: GDPR and GMC Confidentiality<\/h3>\n\n<p>The GMC&#8217;s <em>Confidentiality: Good Practice in Handling Patient Information<\/em> applies with equal force online: &#8220;You must not disclose identifiable information about patients, when using social media, unless you have explicit consent to do so\u2014for example, for educational purposes.&#8221; Under the GDPR, health data is special\u2011category data requiring explicit consent for processing, and patients have the right to withdraw consent at any time. Source: <a href=\"https:\/\/www.gmc-uk.org\/professional-standards\/the-professional-standards\/using-social-media-as-a-medical-professional\" target=\"_blank\" rel=\"noopener noreferrer\">GMC Social Media Guidance<\/a>.<\/p>\n\n<h2>8. Platform\u2011Specific Policies: Meta, LinkedIn, and Google<\/h2>\n\n<p>Even if a physician&#8217;s content complies with the ethical codes of his or her jurisdiction, it must also comply with the terms of service of the platforms on which it appears. The major platforms have introduced health\u2011specific advertising and content restrictions:<\/p>\n<ul>\n  <li><strong>Meta (Facebook\/Instagram):<\/strong> Restricts advertisements that imply negative self\u2011perception or promote unrealistic body image. Cosmetic procedure advertising faces heightened scrutiny, and before\u2011after images may be rejected or removed. Source: <a href=\"https:\/\/transparency.meta.com\/policies\/ad-standards\/\" target=\"_blank\" rel=\"noopener noreferrer\">Meta Ad Standards<\/a>.<\/li>\n  <li><strong>LinkedIn:<\/strong> Prohibits the use of its Insight Tag for retargeting healthcare advertisements and restricts the promotion of prescription drugs to consumers. Source: <a href=\"https:\/\/www.linkedin.com\/legal\/ads-policy\" target=\"_blank\" rel=\"noopener noreferrer\">LinkedIn Advertising Policies<\/a>.<\/li>\n  <li><strong>Google:<\/strong> Requires certification for healthcare and medical device advertising in certain regions (e.g., G2 certification) and enforces strict policies against misleading health claims. Source: <a href=\"https:\/\/support.google.com\/adspolicy\/answer\/176031\" target=\"_blank\" rel=\"noopener noreferrer\">Google Ads Healthcare and Medicines Policy<\/a>.<\/li>\n<\/ul>\n\n<p>Violating platform policies can result in content removal, account suspension, or permanent de\u2011platforming\u2014cutting off the physician&#8217;s legitimate educational channel alongside any questionable promotional content.<\/p>\n\n<p><a href=\"\/lorex-en.html#c4\" target=\"_blank\">Discover why series logic outperforms one\u2011off promotional posts \u2192<\/a><\/p>\n\n<h2>9. AI\u2011Generated Content: A New Frontier of Legal and Ethical Risk<\/h2>\n\n<p>The increasing use of generative AI tools (large language models, image generators, and synthetic voice technology) to draft social\u2011media posts, patient\u2011education materials, or marketing copy has introduced a new dimension of legal and ethical risk.<\/p>\n\n<h3>9.1 The AMA&#8217;s 2026 Deepfake Framework<\/h3>\n\n<p>As outlined in Section 4.2 above, the AMA&#8217;s framework addresses the most visible AI risk\u2014impersonation\u2014but the broader issue of AI\u2011assisted content creation is governed by existing standards: the physician is <strong>fully responsible for all published content<\/strong>, whether drafted by a human or generated by a machine. <a href=\"https:\/\/www.ama-assn.org\/press-center\/ama-press-releases\/ama-urges-physician-protections-against-ai-deepfake-impersonation\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: AMA)<\/a><\/p>\n\n<h3>9.2 Hallucinated References and Scientific Integrity<\/h3>\n\n<p>AI models may generate plausible but non\u2011existent citations, journal articles, or statistics. Publishing such content may constitute professional misconduct, even if the physician did not intend to deceive. The GMC&#8217;s requirement that published information be &#8220;accurate based on professional medical judgment&#8221; places the burden of verification squarely on the physician. &#8220;ChatGPT wrote it&#8221; is not a defense in any regulatory proceeding. <a href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1350\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Kosin Medical Journal)<\/a><\/p>\n\n<h3>9.3 Data Privacy and AI Training Risks<\/h3>\n\n<p>Inputting patient data (even partially anonymized) into a public AI tool may violate HIPAA, the GDPR, KVKK, or equivalent local laws, as the data may be stored, processed, or used for model training without the patient&#8217;s consent. The AMA recommends that all AI\u2011assisted patient communication be reviewed by a qualified human clinician before publication. <a href=\"https:\/\/mindthebleep.com\/am-i-allowed-to-use-artificial-intelligence-as-a-doctor\/\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Mind The Bleep)<\/a><\/p>\n\n<h2>10. Sanctions and Real\u2011World Enforcement<\/h2>\n\n<p>The risk of regulatory action for social\u2011media violations is not theoretical. Enforcement data from multiple jurisdictions confirms that regulators are actively monitoring and sanctioning physicians for online misconduct.<\/p>\n\n<h3>10.1 Turkey<\/h3>\n\n<p>Turkey&#8217;s Provincial Evaluation Commissions actively monitor social media using AI tools. Since the 2025 Regulation took effect, hundreds of physicians have received administrative fines; several private clinics have had their licenses suspended for repeated before\u2011after photo violations; and in extreme cases, criminal complaints have been filed for practicing medicine outside the scope of law when doctors advertised unapproved treatments. <a href=\"https:\/\/oranpartners.com\/articles\/cosmetic-influencers-medical-malpractice-turkey\/\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Oran Partners)<\/a><\/p>\n\n<h3>10.2 United States<\/h3>\n\n<p>State medical boards have broad authority to discipline licensees for unprofessional conduct, including social\u2011media violations. The Medical Board of California, for example, may issue public reprimands, suspend licenses, or revoke licenses for violations of the Medical Practice Act. Ohio Revised Code \u00a7\u202f4731.22 authorizes the State Medical Board to limit, revoke, or suspend a license for violations including &#8220;failure to maintain minimal standards of care&#8221; and &#8220;violation of any provision of a code of ethics.&#8221; Enforcement actions are published on the relevant Board&#8217;s website and remain available indefinitely. <a href=\"https:\/\/www.mbc.ca.gov\/Enforcement\/\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Medical Board of California)<\/a><\/p>\n\n<h3>10.3 United Kingdom<\/h3>\n\n<p>The Medical Practitioners Tribunal Service (MPTS), which adjudicates fitness\u2011to\u2011practise cases referred by the GMC, has sanctioned doctors for social\u2011media posts that harassed colleagues, disclosed patient information, or expressed racist views. Sanctions range from warnings and conditions on practice to suspension and erasure from the medical register. <a href=\"https:\/\/www.gmc-uk.org\/api\/gmc\/lrmpdocuments\/download?dr=4160896&#038;document=111148274&#038;documentType=hearing\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: GMC Tribunal)<\/a><\/p>\n\n<h3>10.4 Australia<\/h3>\n\n<p>The Medical Board of Australia has referred practitioners to disciplinary tribunals for breaches of the advertising guidelines, including the use of patient testimonials and misleading claims about treatment efficacy. <a href=\"https:\/\/www.medicalboard.gov.au\/Codes-Guidelines-Policies\/Guidelines-for-advertising-regulated-health-services.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Medical Board of Australia)<\/a><\/p>\n\n<h2>11. Building a Legally Compliant Social Media Presence: A 10\u2011Principle Framework<\/h2>\n\n<p>Drawing on the regulatory frameworks surveyed, the following principles provide a jurisdiction\u2011neutral guide for physicians seeking to use social media for professional purposes without violating advertising restrictions or ethical obligations:<\/p>\n\n<ol>\n  <li><strong>Educate, do not promote.<\/strong> Each post should be self\u2011contained as an educational unit: it should answer a genuine medical question or correct a known piece of misinformation. If the primary purpose of a post is to attract patients to your practice, it is likely advertising\u2014and likely prohibited.<\/li>\n  <li><strong>Identify yourself.<\/strong> State your full name, qualifications, and specialty so that the audience can assess the credibility and limits of the information. The GMC explicitly recommends this; the CNOM Charter requires it.<\/li>\n  <li><strong>Disclose all conflicts.<\/strong> If a post mentions a product, service, or clinic with which you have a financial relationship, disclose that relationship clearly and conspicuously. The FTC requires #ad or #sponsored labels; the AMA and GMC impose equivalent obligations.<\/li>\n  <li><strong>Never guarantee outcomes.<\/strong> Medical outcomes are inherently uncertain; any statement that implies a guaranteed result is both misleading and ethically prohibited across all surveyed jurisdictions.<\/li>\n  <li><strong>Respect patient privacy absolutely.<\/strong> Obtain written consent for any identifiable patient information, and consider whether even anonymized case studies could be re\u2011identified. HIPAA, GDPR, and KVKK all impose strict liability for breaches.<\/li>\n  <li><strong>Review AI\u2011generated content personally.<\/strong> Never publish AI\u2011generated text, images, or video without a thorough human review for accuracy, bias, and legal compliance. The physician remains the legal and ethical guarantor of all published content.<\/li>\n  <li><strong>Avoid before\u2011after images.<\/strong> Even where not explicitly prohibited, these are treated as presumptively promotional by most medical regulators. The educational justification rarely outweighs the risk.<\/li>\n  <li><strong>Maintain professional boundaries.<\/strong> Do not &#8220;friend&#8221; current patients or engage in personal social\u2011media interactions with them. The GMC, AMA, and CNOM all warn against boundary blurring.<\/li>\n  <li><strong>Monitor your digital footprint.<\/strong> Regularly search for your name and professional profile to identify and address inaccurate, misleading, or unauthorized content posted by third parties. The AMA explicitly recommends routine monitoring.<\/li>\n  <li><strong>Document compliance.<\/strong> Keep records of patient consents, content review processes, and AI\u2011usage logs. In the event of a regulatory inquiry, contemporaneous documentation is the best defense.<\/li>\n<\/ol>\n\n<p><a href=\"\/lorex-en.html#projeTasarimi\" target=\"_blank\">Get a closer look at the project design phase \u2192<\/a><\/p>\n\n<h2>12. The Long\u2011Term Payoff: Trust Over Attention<\/h2>\n\n<p>Patients are increasingly skeptical of online health information. A physician who consistently produces evidence\u2011based, educational content\u2014without resorting to advertising tricks\u2014builds genuine trust. That trust translates into patient loyalty, better health outcomes, and professional referrals. Importantly, a compliant educational series becomes a <strong>media asset<\/strong> that can be repurposed for years, unlike a single promotional post that may be deleted after a regulatory complaint.<\/p>\n\n<p>The 2025\u20132026 regulatory developments surveyed in this article all reflect a common direction of travel: physicians are not prohibited from using social media, but they are held to a higher standard of transparency, accuracy, and professionalism than any other category of content creator. The physician who understands and internalizes this standard\u2014who treats every post as a professional act subject to the same ethical scrutiny as a consultation, a prescription, or a published article\u2014will not only avoid regulatory sanction but will build lasting professional authority in an information environment increasingly polluted by misinformation and commercial exploitation.<\/p>\n\n<p><strong>Ready to build a medical content series that educates patients without violating advertising rules?<\/strong> The LOREX model provides a structured, legally compliant framework for physicians. Stop risking your license\u2014start building lasting educational authority.<\/p>\n\n<p><a href=\"\/lorex-en.html#basvuru\" target=\"_blank\">Apply to start your LOREX project today \u2192<\/a><\/p>\n\n<hr>\n\n<h2>Frequently Asked Questions (FAQ)<\/h2>\n\n<div itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">Can a doctor share a before\u2011after photo on Instagram for educational purposes?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>Even where not explicitly prohibited by statute, before\u2011after photos are treated as presumptively promotional by most medical regulators. The GMC warns that such content blurs professional boundaries, and the CNOM Charter emphasizes that content must not create unrealistic expectations. If a physician wishes to use clinical images for genuine education (e.g., in a peer\u2011reviewed journal or an accredited CME presentation), the images must be fully anonymized, used only with written patient consent, and presented in a strictly scientific context\u2014never on a public\u2011facing commercial social\u2011media account. In Turkey, the 2025 Regulation imposes additional specific requirements: a dedicated Visual Content Consent Form (Annex\u20111), no filters or editing, mandatory date markers, and comments disabled. <a href=\"https:\/\/www.tdb.org.tr\/icerik_goster.php?Id=4361\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: TDB)<\/a><\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">Is it legal for a doctor to respond to patient reviews on Google Maps or similar platforms?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>Physicians may generally acknowledge reviews, but must not disclose protected health information or engage in arguments with reviewers. Thanking a patient for positive feedback is typically acceptable; offering discounts, soliciting additional patients, or revealing clinical details in a response is not. Several U.S. state medical boards and the GMC have indicated that responses to online reviews are subject to the same confidentiality obligations as any other public communication. Under HIPAA and the GDPR, a response that confirms or implies a reviewer&#8217;s status as a patient may itself constitute a breach of confidentiality.<\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">Can a physician use AI to write educational health blog posts or social\u2011media content?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>Yes\u2014provided the physician personally reviews and verifies every factual claim, citation, and clinical statement before publication. The physician remains fully responsible for the accuracy and ethical compliance of the published content. Relying on AI\u2011generated text without human review is likely to breach the AMA&#8217;s and GMC&#8217;s requirement that published information be &#8220;accurate based on professional medical judgment.&#8221; Additionally, inputting patient\u2011specific information into a public AI model may violate HIPAA, GDPR, KVKK, or equivalent privacy legislation, as the data may become part of the model&#8217;s training set without the patient&#8217;s consent. <a href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1350\" target=\"_blank\" rel=\"noopener noreferrer\">(Source: Kosin Medical Journal)<\/a><\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">What are the consequences of posting a discount or promotional offer for medical services?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>The consequences vary by jurisdiction but can be severe. Under Turkey&#8217;s 2025 Regulation, such a post is a clear violation of Article 5(2)(e) (prohibition on commercial campaigns), exposing the physician to administrative fines (starting at several thousand lira, doubling for repeat offenses), possible disciplinary action by the medical chamber, and referral to the public prosecutor if patient harm is alleged. In the United Kingdom, the GMC requires that any advertising of services be honest and not misleading; a discount offer could be interpreted as exploiting patient vulnerability and may trigger a fitness\u2011to\u2011practise investigation. In the United States, a state medical board may investigate such a post as unprofessional conduct. In Australia, the Medical Board&#8217;s advertising guidelines would likely treat the post as a breach of the prohibition on misleading advertising.<\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">Can a doctor post &#8220;We have the latest technology&#8221; on LinkedIn without violating advertising rules?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>Factual statements about available equipment are generally permissible, but qualitative claims (&#8220;latest,&#8221; &#8220;most advanced,&#8221; &#8220;best&#8221;) are treated as comparative advertising and may attract regulatory scrutiny. The safest approach is to describe the technology in objective, verifiable terms without implying superiority over alternatives. The GMC&#8217;s requirement that communications not be &#8220;false or misleading&#8221; applies to all forms of promotional content, including statements about facilities and equipment. In Turkey, Article 5(2)(\u00e7) of the 2025 Regulation prohibits claims that create an impression of superiority over competitors. Always include a mandatory informational disclaimer.<\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n  <div itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n    <h3 itemprop=\"name\">Can a doctor share patient success stories or testimonials on social media if the patient agrees?<\/h3>\n    <div itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n      <div itemprop=\"text\">\n        <p>No\u2014or only under the narrowest of circumstances. The Medical Board of Australia&#8217;s advertising guidelines impose an absolute prohibition on the use of patient testimonials in advertising, even with consent. The GMC&#8217;s guidance warns that sharing patient stories risks breaching confidentiality and blurring professional boundaries. Turkey&#8217;s 2025 Regulation treats patient testimonials as misleading advertising under Article 5(2)(d). The India NMC regulations prohibit any form of patient solicitation or testimonial publication. Even where not explicitly banned, the AMA&#8217;s professionalism standards and the CNOM Charter would treat a patient testimonial as incompatible with the dignity of the profession if it serves a promotional rather than a genuinely educational purpose.<\/p>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/div>\n\n<hr>\n<p><em>This article is part of the LOREX series on compliant healthcare content and IP development. For more insights, visit our blog. Last updated: 14 May 2026.<\/em><\/p>\n\n<style>\n  .faq-question {\n    cursor: pointer;\n    background: #f5f5f5;\n    padding: 12px 16px;\n    margin: 8px 0 0 0;\n    border-radius: 8px;\n    font-weight: 600;\n    transition: background 0.2s ease;\n  }\n  .faq-question:hover {\n    background: #eaeaea;\n  }\n  .faq-answer {\n    display: none;\n    padding: 12px 16px;\n    background: #ffffff;\n    border-left: 3px solid #ff0000;\n    margin-bottom: 8px;\n    border-radius: 0 0 8px 8px;\n  }\n  .faq-answer.show {\n    display: block;\n  }\n<\/style>\n\n<script>\n  document.addEventListener(\"DOMContentLoaded\", function() {\n    var questions = document.querySelectorAll('.faq-question');\n    questions.forEach(function(question) {\n      question.addEventListener('click', function() {\n        var answer = this.nextElementSibling;\n        if (answer.classList.contains('faq-answer')) {\n          answer.classList.toggle('show');\n        }\n      });\n    });\n  });\n<\/script>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Doctor on Social Media: Educational Content vs. Covert Advertising \u2013 Legal Boundaries and Risks Disclaimer: This content is for educational and informational purposes only [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"page_builder":"","footnotes":""},"categories":[138],"tags":[190,193,192,191,187,189,197,92,195,196,194,188],"class_list":["post-8027","post","type-post","status-publish","format-standard","hentry","category-legal","tag-ai-in-medical-content","tag-ama-ethics","tag-before-after-photos-prohibition","tag-compliant-health-content","tag-doctor-social-media","tag-gmc-social-media","tag-healthcare-marketing-restrictions","tag-lorex-model","tag-medical-advertising-ban","tag-medical-misconduct","tag-patient-privacy-kvkk","tag-turkish-healthcare-regulation"],"acf":{"choi\u0441e_menu_page":"global_settings","full_width":false,"header_transparent":false,"header_white":false,"menu_align_page":"default","menu_style":""},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Tayfun Demirhan\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Lorex Works Blog -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Doctor on Social Media: Educational Content vs Covert Advertising\" \/>\n\t\t<meta property=\"og:description\" content=\"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-11T15:03:28+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-14T15:07:45+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@lorexworks\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Doctor on Social Media: Educational Content vs Covert Advertising\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@lorexworks\" \/>\n\t\t<meta name=\"twitter:image\" content=\"http:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#blogposting\",\"name\":\"Doctor on Social Media: Educational Content vs Covert Advertising\",\"headline\":\"Doctor on Social Media: Educational Content vs Covert Advertising\\u00a0\",\"author\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/author\\\/lorexworks\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#organization\"},\"datePublished\":\"2026-05-11T15:03:28+00:00\",\"dateModified\":\"2026-05-14T15:07:45+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#webpage\"},\"articleSection\":\"LEGAL, AI in medical content, AMA ethics, before-after photos prohibition, compliant health content, doctor social media, GMC social media, healthcare marketing restrictions, LOREX model, medical advertising ban, medical misconduct, patient privacy KVKK, Turkish healthcare regulation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/category\\\/legal\\\/#listItem\",\"name\":\"LEGAL\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/category\\\/legal\\\/#listItem\",\"position\":2,\"name\":\"LEGAL\",\"item\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/category\\\/legal\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#listItem\",\"name\":\"Doctor on Social Media: Educational Content vs Covert Advertising\\u00a0\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#listItem\",\"position\":3,\"name\":\"Doctor on Social Media: Educational Content vs Covert Advertising\\u00a0\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/category\\\/legal\\\/#listItem\",\"name\":\"LEGAL\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#organization\",\"name\":\"Lorex Works Blog\",\"url\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/lorexworks\",\"https:\\\/\\\/www.instagram.com\\\/lorexworks\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/author\\\/lorexworks\\\/#author\",\"url\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/author\\\/lorexworks\\\/\",\"name\":\"Tayfun Demirhan\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c30ce287c4e856a4ad7fcff367e36589055250514a80a36e9bb7ebd501c81101?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Tayfun Demirhan\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#webpage\",\"url\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/\",\"name\":\"Doctor on Social Media: Educational Content vs Covert Advertising\",\"description\":\"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\\\/GMC guidance, before\\u2011after photos, AI risks, and penalties.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/doctor-on-social-media-educational-content-vs-covert-advertising\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/author\\\/lorexworks\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/author\\\/lorexworks\\\/#author\"},\"datePublished\":\"2026-05-11T15:03:28+00:00\",\"dateModified\":\"2026-05-14T15:07:45+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/\",\"name\":\"Lorex Works Blog\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/lorexworks.com\\\/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Doctor on Social Media: Educational Content vs Covert Advertising","description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","canonical_url":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#blogposting","name":"Doctor on Social Media: Educational Content vs Covert Advertising","headline":"Doctor on Social Media: Educational Content vs Covert Advertising\u00a0","author":{"@id":"https:\/\/lorexworks.com\/blog\/author\/lorexworks\/#author"},"publisher":{"@id":"https:\/\/lorexworks.com\/blog\/#organization"},"datePublished":"2026-05-11T15:03:28+00:00","dateModified":"2026-05-14T15:07:45+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#webpage"},"isPartOf":{"@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#webpage"},"articleSection":"LEGAL, AI in medical content, AMA ethics, before-after photos prohibition, compliant health content, doctor social media, GMC social media, healthcare marketing restrictions, LOREX model, medical advertising ban, medical misconduct, patient privacy KVKK, Turkish healthcare regulation"},{"@type":"BreadcrumbList","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/#listItem","position":1,"name":"Home","item":"https:\/\/lorexworks.com\/blog\/","nextItem":{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/category\/legal\/#listItem","name":"LEGAL"}},{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/category\/legal\/#listItem","position":2,"name":"LEGAL","item":"https:\/\/lorexworks.com\/blog\/category\/legal\/","nextItem":{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#listItem","name":"Doctor on Social Media: Educational Content vs Covert Advertising\u00a0"},"previousItem":{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#listItem","position":3,"name":"Doctor on Social Media: Educational Content vs Covert Advertising\u00a0","previousItem":{"@type":"ListItem","@id":"https:\/\/lorexworks.com\/blog\/category\/legal\/#listItem","name":"LEGAL"}}]},{"@type":"Organization","@id":"https:\/\/lorexworks.com\/blog\/#organization","name":"Lorex Works Blog","url":"https:\/\/lorexworks.com\/blog\/","sameAs":["https:\/\/x.com\/lorexworks","https:\/\/www.instagram.com\/lorexworks\/"]},{"@type":"Person","@id":"https:\/\/lorexworks.com\/blog\/author\/lorexworks\/#author","url":"https:\/\/lorexworks.com\/blog\/author\/lorexworks\/","name":"Tayfun Demirhan","image":{"@type":"ImageObject","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/c30ce287c4e856a4ad7fcff367e36589055250514a80a36e9bb7ebd501c81101?s=96&d=mm&r=g","width":96,"height":96,"caption":"Tayfun Demirhan"}},{"@type":"WebPage","@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#webpage","url":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/","name":"Doctor on Social Media: Educational Content vs Covert Advertising","description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/lorexworks.com\/blog\/#website"},"breadcrumb":{"@id":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/#breadcrumblist"},"author":{"@id":"https:\/\/lorexworks.com\/blog\/author\/lorexworks\/#author"},"creator":{"@id":"https:\/\/lorexworks.com\/blog\/author\/lorexworks\/#author"},"datePublished":"2026-05-11T15:03:28+00:00","dateModified":"2026-05-14T15:07:45+00:00"},{"@type":"WebSite","@id":"https:\/\/lorexworks.com\/blog\/#website","url":"https:\/\/lorexworks.com\/blog\/","name":"Lorex Works Blog","inLanguage":"en-US","publisher":{"@id":"https:\/\/lorexworks.com\/blog\/#organization"}}]},"og:locale":"en_US","og:site_name":"Lorex Works Blog -","og:type":"article","og:title":"Doctor on Social Media: Educational Content vs Covert Advertising","og:description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","og:url":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/","og:image":"https:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp","og:image:secure_url":"https:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp","article:published_time":"2026-05-11T15:03:28+00:00","article:modified_time":"2026-05-14T15:07:45+00:00","twitter:card":"summary_large_image","twitter:site":"@lorexworks","twitter:title":"Doctor on Social Media: Educational Content vs Covert Advertising","twitter:description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","twitter:creator":"@lorexworks","twitter:image":"http:\/\/lorexworks.com\/blog\/wp-content\/uploads\/2026\/05\/l-x-1.webp"},"aioseo_meta_data":{"post_id":"8027","title":"Doctor on Social Media: Educational Content vs Covert Advertising","description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","keywords":null,"keyphrases":{"focus":{"keyphrase":"Doctor","score":64,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInURL":{"score":5,"maxScore":5,"error":0},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":"Doctor on Social Media: Educational Content vs Covert Advertising","og_description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":"Doctor on Social Media: Educational Content vs Covert Advertising","twitter_description":"Doctor social media rules: what is educational vs prohibited advertising? Turkish 2025 Regulation, AMA\/GMC guidance, before\u2011after photos, AI risks, and penalties.","schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-05-14 14:26:01","updated":"2026-05-14 15:24:30","seo_analyzer_scan_date":null,"focus_keyword":"Doctor","additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/lorexworks.com\/blog\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/lorexworks.com\/blog\/category\/legal\/\" title=\"LEGAL\">LEGAL<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tDoctor on Social Media: Educational Content vs Covert Advertising \n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/lorexworks.com\/blog\/"},{"label":"LEGAL","link":"https:\/\/lorexworks.com\/blog\/category\/legal\/"},{"label":"Doctor on Social Media: Educational Content vs Covert Advertising\u00a0","link":"https:\/\/lorexworks.com\/blog\/doctor-on-social-media-educational-content-vs-covert-advertising\/"}],"_links":{"self":[{"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/posts\/8027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/comments?post=8027"}],"version-history":[{"count":3,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/posts\/8027\/revisions"}],"predecessor-version":[{"id":8030,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/posts\/8027\/revisions\/8030"}],"wp:attachment":[{"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/media?parent=8027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/categories?post=8027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lorexworks.com\/blog\/wp-json\/wp\/v2\/tags?post=8027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}